نتایج جستجو برای: leishmaniasis vaccine

تعداد نتایج: 120929  

Journal: :iranian journal of pharmaceutical research 0
mahmoodreza jaafari biotechnology and nanotechnology research center, school of pharmacy, mashhad university of medical sciences (mums), mashhad, iran mohsen tafaghodia nanotechnology research center, school of pharmacy, mashhad university of medical sciences, p.o. box 91775-1365, mashhad, iran maryam maryam eskandari nanotechnology research center, school of pharmacy, mashhad university of medical sciences, p.o. box 91775-1365, mashhad, iran ali khamesipour center for research and training in skin diseases and leprosy, tehran university of medical sciences, tehran, iran

leishmania antigens are weak immunogens and need to be potentiated by various adjuvants and delivery systems. alginate microspheres as an antigen delivery system and quillaja saponins (qs) as an immunoadjuvant have been used to enhance the immune response against autoclaved leishmania major (alm). microspheres were prepared by an emulsification technique and characterized for size, encapsulatio...

Journal: :Infection and immunity 2006
Rosalind Polley Simona Stager Sara Prickett Asher Maroof Soombul Zubairi Deborah F Smith Paul M Kaye

CD8+ T cells have a protective role in experimental visceral leishmaniasis. However, the observation that inflammatory cytokines induce bystander activation of CD8+ T cells questions the need for antigen-dependent effector function. Here, we demonstrate that successful adoptive immunotherapy with CD8+ T cells is strictly dependent upon the presence of cognate antigen.

2016
Keerti Rawat Narendra K Yadav Sumit Joshi Sneha Ratnapriya Amogh A Sahasrabuddhe Anuradha Dube

php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, p...

2017
Rajiv Kumar Shashi Bhushan Chauhan Susanna S. Ng Shyam Sundar Christian R. Engwerda

Leishmaniasis encompasses a group of diseases caused by protozoan parasites belonging to the genus Leishmania. These diseases range from life threatening visceral forms to self-healing cutaneous lesions, and each disease manifestations can progress to complications involving dissemination of parasites to skin or mucosal tissue. A feature of leishmaniasis is the key role host immune responses pl...

Journal: :Memorias do Instituto Oswaldo Cruz 2010
Wilson Mayrink Carlos Alberto Pereira Tavares Rosangela Barbosa de Deus Melina Barros Pinheiro Tânia Mara Pinto Dabés Guimarães Hélida Monteiro de Andrade Carlos Alberto da Costa Vicente de Paulo Coelho Peixoto da Toledo

For decades thimerosal has been used as a preservative in the candidate vaccine for cutaneous leishmaniasis, which was developed by Mayrink et al. The use of thimerosal in humans has been banned due to its mercury content. This study addresses the standardization of phenol as a new candidate vaccine preservative. We have found that the proteolytic activity was abolished when the test was conduc...

2014
Rajiv Kumar Christian Engwerda

Leishmaniasis is a parasitic disease that encompasses a range of clinical manifestations affecting people in tropical and subtropical regions of the world. Epidemiological and experimental data indicate that protection from disease can be achieved in most people. In addition, we know how the host immune system must respond to infection in order to control parasite growth. However, there is stil...

Journal: :Parasite 1994
L Campino G Santos-Gomes F Pratlong J P Dedet P Abranches

The spread of HIV infection into leishmaniasis endemic areas has increased the incidence of immunosupressed patients with kalaazar in Portugal. The dermotropic zymodeme MON-24 of leishmania infantum has been already isolated from a Portuguese AIDS patient, as in some other Mediterranean countries. In this paper we report the isolation of L. donovani MON-18 from a drug addicted Portuguese patien...

Journal: :Antimicrobial agents and chemotherapy 2014
Cristiana T Trinconi Juliana Q Reimão Jenicer K U Yokoyama-Yasunaka Danilo C Miguel Silvia R B Uliana

Leishmaniasis chemotherapy remains very challenging. The high cost of active drugs, along with the severity of their side effects and the increasing failure rate of the current therapeutic schemes, calls for the discovery of new active drugs and schemes of treatment. The use of combination therapy has gained much attention in recent years as a possible strategy for overcoming the various shortc...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید